REGN Reports Encouraging Data on Gene Therapy for Genetic Hearing Loss
Regeneron Pharmaceuticals, Inc. REGN announced updated data on its investigational gene therapy DB-OTO from the CHORD study.This gene therapy is...
Regeneron Pharmaceuticals, Inc. REGN announced updated data on its investigational gene therapy DB-OTO from the CHORD study.This gene therapy is...
Tel Aviv , September 15 (ANI/TPS): Israeli and US scientists have developed a promising new gene therapy that could one...
Genetic Engineering Market Size and Forecast 2025 to 2034 The global genetic engineering market size was calculated at USD 1.62...
Using gene therapy to treat hereditary deafness is safe and effective in both children and adults, according to new findings...
Credit: Pixabay/CC0 Public Domain A study evaluating a pioneering lentivirus (LV)-mediated gene therapy trial for classical Fabry disease showed promising...
Motor neuron disorders have a devastating impact on the lives of those affected. Over the last 10 years, researchers at...
Table of Contents Table of Contents Quick Summary Ask the Chatbot a Question Vaccine developmentThe generation of vaccines relies heavily...
It has been described as a revolutionary technology — and won its inventors a Nobel Prize.CRISPR gene editing, often simply...
NEW YORK and TRUMBULL, Conn., April 30, 2025 /PRNewswire/ -- Apertura Gene Therapy, a biotechnology company focused on innovative gene therapy...